Intel shares trade at $86.96 today, up 127.2 percent from $38.16 on Oct. 23, 2025—a sharp move driven by specific wins: Tesla's Terafab choosing Intel's 14A process and Google placing a multi-million dollar order for Intel's TPUs.
But the bull case is now colliding with reality. Q2 2026 revenue reached $16.13 billion, up from $12.86 billion in Q2 2025. Yet Intel posted a larger net loss and its net margin deteriorated further into negative territory.
This is the critical disconnect. On Oct. 23, 2025, a bullish thesis projected a fair value of $79—a 107 percent upside from that price—on the assumption of 10 percent revenue growth and 22 percent profit margins over five years. That case hinged on manufacturing execution and a cyclical PC rebound.
A cautious case at the time pegged fair value at $25.18, assuming 3.5 percent revenue growth and margins improving only to 7.8 percent over three years. Today, with Intel trading at $86.96, even that pessimistic target sits below current levels.
The lesson is stark: contract wins and positive AI optics do not substitute for net margin expansion. Intel's foundry strategy requires the company to execute five new process nodes in four years while competing against TSMC's proven track record and AMD's strengthened position in x86 CPUs. Manufacturing delays have plagued Intel for years. There is no guarantee the company can compress its development timeline or that regaining parity with TSMC will be enough to overcome AMD's credibility in server and PC chips.
For investors holding or considering Intel at $86.96, the thesis now requires a flawless execution on multiple fronts—and a market willing to pay for upside potential rather than current profitability. That is a bet, not a valuation.
